Search

everythinglearnresearchcommunity

for

Search:↓

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Finasteride may help treat autism by reducing inflammation and oxidative stress.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Targeting IL-17 could help treat pattern hair loss.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Apremilast may help treat hair loss in alopecia areata.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.